Patents
Patents for C07C 225 - Compounds containing amino groups and doubly-bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly-bound oxygen atoms not being part of a cho group, e.g. amino ketones (4,302)
08/2006
08/16/2006CN1269819C Synthesis of temozolomide and analogs
08/15/2006US7091240 Destroying tumor cell vasculation; antitumor agents; anticancer agents
08/10/2006US20060177621 O-coordinated metal chelates and their use in optical recording media having high storage capacity
08/09/2006EP1687253A2 Diphenylamine derivatives
07/2006
07/27/2006US20060166990 Novel aminobenzophenone compounds
07/27/2006CA2593667A1 Process for the preparation of fenoldopam mesylate
07/26/2006EP1682486A1 Quaternary amino-functional chalcones
07/26/2006EP0902003B1 Novel tetralone or benzopyranone derivatives and process for producing the same
07/26/2006CN1266118C Novel delta-amino-gamma-hydroxy-omega-aryl-alkanoic acid amides
07/26/2006CN1266115C Preparation method of 2-(2-arylmorpholine-2-yl)-ethanol and intermediate
07/25/2006US7081550 Aromatic diamine; electrolytic cells
07/20/2006DE102005001053A1 Quadratsäurederivate Squaric acid derivatives
07/18/2006US7077872 Dyeing keratin fibers using developer ,coupler, oxidizer
07/13/2006WO2006072785A2 Base stable ionic liquids
07/13/2006WO2006072354A1 Squaric acid derivatives
07/13/2006CA2594388A1 Squaric acid derivatives
07/12/2006CN1800145A Substituted 2-dialkylaminoalkylbiphenyl derivatives
07/12/2006CN1263731C Novel immunotherapeutic agents and their use in production of cytokine levels
07/12/2006CN1263514C Fluoro labeled anthracyclinone and anthracycline derivatives
07/11/2006US7074835 Anticancer agents
07/06/2006WO2006069798A1 Process for the preparation of chiral amines
07/06/2006WO2005108347A3 Substituted enaminones, their derivatives and uses thereof
07/06/2006US20060149058 Cyclization of compounds such as -[Benzyl(2-hydroxyethyl)amino]-2-(3,4-difluorophenyl)but-3-en-2-ol to produce 2-vinyl-2-arylmorpholine derivatives
07/06/2006US20060148893 Chemical compounds
07/06/2006US20060148777 1,5-Bis-((2-dimethylamino-N-oxide)ethyl)amino)-4,8-dihydroxyanthracene-9,10-dione; DRAQ5 dyes;analyzing cells/biological material and detecting emitted fluorescence signal; cell permeant DNA-interactive agents providing a fluorescence signature into the infra red spectra; red-line emitting lasers
07/06/2006DE10140107B4 Verfahren zur Herstellung von 1-Amino-4-hydroxyanthrachinonen A process for the preparation of 1-amino-4-hydroxyanthraquinones
07/04/2006US7071225 Arylaminopropane analogues and their use for the treatment of glaucoma
06/2006
06/29/2006US20060142252 Tubulin binding agents and corresponding prodrug constructs
06/28/2006EP1259243B1 Bupropion metabolites and methods of their synthesis and use
06/22/2006US20060135775 Intermediates and process for the production of optically active quinolonecarboxylic acid derivatives
06/22/2006US20060135622 Amino alcohol derivative, addition salt thereof, and immunosuppressant
06/21/2006EP1670740A2 Clear photopolymerizable systems for the preparation of high thickness coatings
06/21/2006EP1556323A4 Metal chelates and methods of using them for time-resolved fluorescence
06/21/2006EP1307420B1 PROCESS FOR SYNTHESIS OF $g(a),$g(b)-UNSATURATED KETONES
06/13/2006US7060427 Anthraquinone and its derivatives
06/08/2006US20060122405 Preparation of 3-methylamino-1-phenyl-1-propanone or 3-methylamino-1-(2-thienyl)-1-propanone; chemical intermediates to central nervous system drugs such as fluoxetine, tomoxetine
06/08/2006US20060122398 Novel nickel-carbene, palladium-carbene and platinum-carbene complexes, their produciton and use in catalytic reactions
06/07/2006EP1039876B1 Direct hair dye compositions and methods containing novel anthraquinone mixtures
06/07/2006CN1784429A Novel trifunctional photoinitiators
06/07/2006CN1781910A Phenylethylamines and condensed rings variants as prodrugs of catecholamines, and their use
06/07/2006CN1781890A 糖皮质激素受体调制剂 Glucocorticoid receptor modulators
06/06/2006US7056347 Intense, stable blue color shades can be obtained in addition to natural and purple or violet shades.
06/01/2006WO2006057323A1 Composition for amyloid-associated disease diagnosis
05/2006
05/30/2006US7053249 Immunoassay; detecting emission
05/24/2006EP1658263A1 Novel aminobenzophenone compounds
05/24/2006EP1250310B1 Method for synthesizing hydrazodicarbonamide
05/24/2006CN1775737A Novel arylamine compound and organic electroluminescence device
05/23/2006CA2173747C Calcium receptor-active arylalkyl amines
05/18/2006US20060106224 Process for the preparation of 2-amino-4,5,6,7-tetrahydro-6-aminobenzothiazoles from cyclohexanes and cyclohexanones as intermediates
05/16/2006US7045533 Such as naphthalen-1-yl-(4-pentyloxy-naphthalen-1-yl)-mehtane for treatment/prevention of diseases/conditions associated with cannobinoid receptor activation such as chronic pain, osteo- and rheumatoid arthritis, teno-synovitis and gout
05/11/2006US20060100463 Selective hydrogenation of nitrogen containing aromatics
05/10/2006EP1654221A2 Aniline derivatived androgen-, glucocorticoid-, mineralcorticoid- and progesterone- receptor modulators
05/09/2006US7041703 Particularly septic shock and/or autoimmune pathologies in which the aetiopathogenic role of inflammatory cytokines has been ascertained
05/02/2006US7038070 Coordination polymerization catalysts
05/02/2006US7038044 Method for preparing 2-(2-arylmorpholin-2-yl)ethanol derivatives and intermediates
05/02/2006US7037912 Enzyme inhibitor contains two or more ligand moieties comprising pyrimidinyl groups covalently linked together by linking groups; keratitis, diabetic retinopathy, angiogenesis, vision defects, ischemia, atherosclerosis,psoriasis, cancer, cirrhosis, diabetes, arthritis, autoimmune disease
04/2006
04/26/2006EP1648856A1 O-coordinated metal chelates and their use in optical recording media having high storage capacity
04/26/2006CN1763060A Metallocene compound, indene compound and application thereof
04/26/2006CN1762957A 2,3-dihydro-1-indene compound and preparation method thereof
04/25/2006US7034015 Interleukin 1 beta and tumour necrosis factor alpha inhibitors
04/25/2006US7033401 3-Aminophenol derivatives substituted in the 2-position, and dyes containing these compounds
04/19/2006CN1252055C Biphenyl carboxamides compounds
04/18/2006USRE39072 2-aminopropane-1,3-diol compounds, medicinal use thereof, and intermediates in synthesizing the same
04/13/2006US20060079685 1-(4-Bromo-benzyl)-4-(4-isopropyl-phenyl)-6-propargyloxy-1H-quinazolin-2-one;osteoporosis, bone disorders, fractures, osteopathy, osteo-malacia, periodontal bone loss or bone loss due to arthritis or osteoarthritis; for promoting the release of parathyroid hormone
04/12/2006EP1644316A2 2-aminobenzoyl derivatives
04/12/2006EP1418879B1 Oxidation hair dyes containing 3-aminophenol derivatives, and novel 3-aminophenol derivatives
04/12/2006EP1311499B1 Bicyclic compounds as h3 receptor ligands
04/12/2006EP1039897B1 Inadone and tetralone compounds for inhibiting cell proliferation
04/12/2006CN1757620A Biphase identification chiral prepn. of chromatographic chiral compound(s)
04/11/2006US7026498 Coordination catalyst containing ligand
04/11/2006CA2198383C Benzene compound and pharmaceutical use thereof
03/2006
03/30/2006US20060069257 Use of specific bidentate ligands, e.g., 2-dicyclohexylphosphino-2'-dimethylamino-biphenyl, in transition metal-catalyzed carbon-heteroatom and carbon-carbon bond-forming reactions including amination and arylation and with aryl halide reactants and amine, boronic acid, borane or ketone reactants
03/29/2006EP1638946A2 2-aminoethyl substituted pyrimidin-2-ones, cyclopropanes, pyrazolines, pyrimidines and benzothiazepines and their use as urotensin ii urotensini ii and somatostatins 5 receptor ligands
03/29/2006EP1379234B1 Halogenated aminobenzophenones and aminobenzoylpyridines as inhibitors of il-1 and tnf
03/29/2006CN1753861A Novel aminobenzophenone compounds
03/29/2006CN1247523C Substituted 1 and 2 naphthol mannich bases
03/29/2006CN1247511C Tropolone derivative
03/28/2006US7019094 Intermediate products, methods for their preparation and use thereof
03/28/2006US7019030 Immunotherapeutic agents
03/22/2006EP1020426B9 Amine derivatives and process for producing the same
03/22/2006CN1751242A Cable testing system
03/22/2006CN1751029A 2-aminoethyl substituted pyrimidin-2-ones, cyclopropanes, pyrazolines, pyrimidines and benzothiazepines and their use as urotensin ii and somatostatin 5 receptor ligands
03/22/2006CN1749237A Tetra substituted chalcone derivative and preparing method and use
03/22/2006CN1246293C Method and apparatus for preparing hydrazo-dicarbonamide using urea as starting material
03/16/2006US20060058380 Novel aminobenzophenone compounds
03/16/2006US20060058300 Intermediates of bupropion metabolites synthesis
03/15/2006EP1175388B1 Spect imaging agents for serotonin transporters
03/15/2006CN1747729A Methods for selectively inhibiting janus tyrosine kinase 3 (jak3)
03/15/2006CN1245376C Substituted 2-dialkylamino alkylbiphenyl derivatives
03/09/2006US20060052600 Amino-functional chalcones
03/08/2006EP1632482A1 Intermediates and process for the production of optically active quinolonecarboxylic acid derivatives
03/08/2006EP1632470A2 Calcium receptor active molecules
03/08/2006CN1745067A Biphenylcarboxamide compound
03/07/2006US7008962 Interleukin-8 (IL-8); compounds such as 3-(2-hydroxy-phenylamino)-4-(2-bromophenylamino)-cyclobut-3-ene-1,2-dione for treating chemokine-mediated diseases such as autoimmune diseases, septic shock, graft versus host disease, allograft rejections
03/02/2006WO2005070869A8 Selective hydrogenation of nitrogen containing aromatics
02/2006
02/23/2006WO2006019955A2 Antiviral methods and compositions
02/23/2006US20060041095 Intermediate products, methods for their preparation and use thereof
02/23/2006US20060040869 Pharmaceutically useful compounds
02/23/2006DE102004039281A1 UV Filter UV filter
02/21/2006US7001926 Tubulin binding agents and corresponding prodrug constructs
1 ... 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 ... 44